Shortly after the April 2015 publication of Guiding Bayer’s Global Innovation Engines To New Heights, an article I wrote featuring Bayer board of management member, Kemal Malik, I received a phone call from Valerie Bowling. The executive director for the Conference Forum and producer of one of my favorite events, Disruptive Innovations to Advance Clinical Trials (DPharm), Bowling said the article sparked an idea. She said the conference, which has consistently been growing in popularity, has typically focused on how to be more innovative in executing clinical trials, but had never focused on the importance of leadership’s role in creating a culture where innovation is able to thrive.
